Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity

NCT02124902 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
148
Enrollment
OTHER
Sponsor class

Stopped Insufficient funding/staff

Conditions

Interventions

Sponsor

Washington University School of Medicine

Collaborators